Fundraising FoxAmorphex Therapeutics Holdings
Andover, US · Founded 2021 · Delaware corporation
Find your way into Amorphex Therapeutics Holdings
Sign up to see every warm intro you have to Amorphex Therapeutics Holdings
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Amorphex Therapeutics Holdings team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RT
ROBERT THOMPSONCHIEF EXECUTIVE OFFICER
Reported raises · per SEC filings
Form D private placements$265K disclosed across 1 round · 2021
▶$265KraisedJan 2023 · 13 investors · PharmaceuticalsRule 506(b)
▶$265KraisedJan 2023 · 13 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- ROBERT THOMPSONExecutive Officer, Director
- Offering amount
- $265K
- Amount sold
- $265K
- Minimum investment
- $5K
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Amorphex Therapeutics Holdings raised?
- Amorphex Therapeutics Holdings has disclosed $265K raised across 1 round.
- Where is Amorphex Therapeutics Holdings headquartered?
- Amorphex Therapeutics Holdings is headquartered in Andover, US.